ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1

Fan, Jingjing; Shen, Xiangfeng; Wang, Yishu; Zhou, Hong-Lan; Liu, Guolong; Li, Yu-Lin; Xu, Zhi-Xiang*吉林大学; 1
Biomedicine and Pharmacotherapy2020-10DOI: 10.1016/j.biopha.2020.110621
8被引9阅读
引用收藏
分享

摘要

Rapidly increasing usages of immune checkpoint therapy for cancer treatment, particularly monoclonal antibodies that target programmed cell death-1 (PD-1) and its ligand PD-L1, have been achieved due to startling durable therapeutic efficacy with limited toxicity. The therapeutics significantly prolonged the overall survival and progression free survival of patients across multiple cancer types. However, the objective response rate of patients receiving this kind of treatment is substantially low. Therefore, it is of great importance to exploit reliable biomarkers that can robustly predict the therapeutic effects. Several biomarkers have been characterized for the selection of patients, which is mainly based on immunological and genetic criteria. Herein, we focus on the current progress regarding the biomarkers for anti-PD-1/PD-L1 therapy.

学科与关键词

关键词
PD-1PD-L1Immune checkpoint therapyBiomarkerCancer
相关
加载中…
  • The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
    Tang, Qing; Chen, Yun; Li, Xiaojuan; Long, Shunqin; Shi, Yao; Yu, Yaya; Wu, Wanyin*; Han, Ling*; Wang, Sumei*Frontiers in Immunology, 2022, 13: 964442.被引 57
  • The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy.
    Wang, Xueping; Wang, Fang; Zhong, Mengjun; Yarden, Yosef; Fu, Liwu*Molecular Cancer, 2020, 19(1): 81.
  • Biomarkers related to immune checkpoint inhibitors therapy
    Li, Na; Hou, Xin; Huang, Shaogang; Tai, Risheng; Lei, Lei; Li, Siyu; Abuliz, Adina; Wang, Geng*; Yang, Shanru*Biomedicine and Pharmacotherapy, 2022, 147: 112470.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2020-10
卷期
第 130 卷
页码
110621
DOI
10.1016/j.biopha.2020.110621
语言
MULTI-LANGUAGE
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81573087, 81772924]; International Cooperation Foundation of Jilin Province [20190701006GH]

作者

  • F

    Fan, Jingjing (第一作者)

    jilin univ

  • S

    Shen, Xiangfeng

    jilin univ

查看全部 7 位作者收起作者
  • W

    Wang, Yishu

    jilin univ

  • Z

    Zhou, Hong-Lan

    jilin univ

  • L

    Liu, Guolong

    1

  • L

    Li, Yu-Lin

    jilin univ

  • X

    Xu, Zhi-Xiang (通讯)

    jilin univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417